Th(2) immune response in patients with dengue during defervescence: preliminary evidence

Ulaganathan Mabalirajan1, Tamilarasu Kadhiravan, S K Sharma

  • 1Molecular Immunology and Immunogenetics Laboratory, Institute of Genomics and Integrative Biology, Delhi, India.

Insights

Dengue patients show a shift towards a T(H)2 immune response, indicated by lower CD4:CD8 ratios and higher IgE levels. This suggests a T(H)2 response during dengue fever recovery.

Area of Science:

  • Immunology
  • Virology
  • Infectious Diseases

Background:

  • Dengue virus infection is associated with immune response alterations.
  • Previous in vitro studies suggested a shift from T(H)1 to T(H)2 immune responses during dengue infection.

Purpose of the Study:

  • To investigate the in vivo immune response in dengue patients around the time of defervescence.
  • To quantify plasma IgE levels, CD4:CD8 lymphocyte ratio, and intracellular IFN-gamma:IL-4 ratio in dengue patients compared to healthy controls.

Main Methods:

  • Plasma IgE levels were measured in 28 dengue patients and healthy controls.
  • CD4:CD8 lymphocyte ratio and intracellular IFN-gamma:IL-4 ratio were assessed in 9 dengue patients and controls.
  • Statistical analysis was performed to compare patient and control groups.

Main Results:

  • Dengue patients had significantly lower CD4:CD8 lymphocyte ratios (P=0.001) and higher plasma IgE levels (P=0.004) compared to controls.
  • The intracellular IFN-gamma:IL-4 ratio was significantly lower in dengue patients (P=0.001), indicating a T(H)2-biased response.
  • These immune changes were observed around the time of defervescence in dengue patients.

Conclusions:

  • The study provides in vivo evidence of a T(H)2 immune response in dengue patients during the recovery phase.
  • The observed immune shift suggests a potential role for T(H)2 cytokines in dengue pathogenesis or resolution.
  • Findings contribute to understanding the complex immune dynamics of dengue virus infection.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...